nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.02.2010 | Focus on

Molecular imaging in cognitive impairment: the relevance of cognitive reserve, importance of multisite longitudinal trials and challenges of standardised analysis

verfasst von: Giovanni Lucignani, Robert Perneczky

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Excerpt

“Education is the best provision for old age” [1]

Aristotle

(384 BC–322 BC)

…

Diogenes Laertius. Lives of Eminent Philosophers, trans. Robert Drew Hicks. (1925). Loeb Classical Library.

Kurz A, Perneczky R. Neurobiology of cognitive disorders. Curr Opin Psychiatry. 2009;22(6):546–51.CrossRefPubMed

Perneczky R, Wagenpfeil S, Lunetta KL, Cupples LA, Green RC, Decarli C, et al. Education attenuates the effect of medial temporal lobe atrophy on cognitive function in Alzheimer’s Disease: the MIRAGE study. J Alzheimers Dis. 2009;17(4):855–62.

Perneczky R, Häussermann P, Drzezga A, Boecker H, Granert O, Feurer R, et al. Fluoro-deoxy-glucose positron emission tomography correlates of impaired activities of daily living in dementia with Lewy bodies: implications for cognitive reserve. Am J Geriatr Psychiatry. 2009;17(3):188–95.CrossRefPubMed

Perneczky R, Drzezga A, Boecker H, Ceballos-Baumann AO, Granert O, Förstl H, et al. Activities of daily living, cerebral glucose metabolism, and cognitive reserve in Lewy body and Parkinson’s disease. Dement Geriatr Cogn Disord. 2008;26(5):475–81.CrossRefPubMed

Perneczky R, Pohl C, Bornschein S, Förstl H, Kurz A, Diehl-Schmid J. Accelerated clinical decline in well-educated patients with frontotemporal lobar degenerations. Eur Arch Psychiatry Clin Neurosci. 2009;259(6):362–7.CrossRefPubMed

Stern Y. Cognitive reserve. Neuropsychologia. 2009;47(10):2015–28.CrossRefPubMed

Van Horn JD, Toga AW. Multisite neuroimaging trials. Curr Opin Neurol. 2009;22(4):370–8.CrossRefPubMed

Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, et al. Alzheimer’s Disease neuroimaging initiative. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Neuroimage. 2009;45(4):1107–16.CrossRefPubMed

10.

Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, et al. The Australian imaging, biomarkers and lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1,112 individuals recruited for a longitudinal study of Alzheimer’s disease. Int Psychogeriatr. 2009;21(4):672–87.CrossRefPubMed

11.

Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, et al. Multicenter standardized ¹⁸F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. J Nucl Med. 2008;49(3):390–8.CrossRefPubMed

12.

Pearlson G. Multisite collaborations and large databases in psychiatric neuroimaging: advantages, problems, and challenges. Schizophr Bull. 2009;35(1):1–2.CrossRefPubMed

13.

Joshi A, Koeppe RA, Fessler JA. Reducing between scanner differences in multi-center PET studies. Neuroimage. 2009;46(1):154–9.CrossRefPubMed

14.

Fouquet M, Desgranges B, Landeau B, Duchesnay E, Mézenge F, de la Sayette V, et al. Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer’s disease. Brain. 2009;132(Pt 8):2058–67.CrossRefPubMed

15.

Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, et al. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2009;36(5):811–22.CrossRefPubMed

16.

Jack Jr CR, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, et al. Alzheimer’s disease neuroimaging initiative. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s disease. Brain. 2009;132(Pt 5):1355–65.CrossRefPubMed

17.

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734–46.CrossRefPubMed

Titel: Molecular imaging in cognitive impairment: the relevance of cognitive reserve, importance of multisite longitudinal trials and challenges of standardised analysis
verfasst von: Giovanni Lucignani
Robert Perneczky
Publikationsdatum: 01.02.2010
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 2/2010
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-009-1361-0

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Molecular imaging in cognitive impairment: the relevance of cognitive reserve, importance of multisite longitudinal trials and challenges of standardised analysis

Excerpt

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2010

Symmetrical nail bed uptake on a 99mTc-HDP bone scan in a patient with Wegener’s granulomatosis

Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with 90Y-labeled biotin

Therapeutic nuclear medicine expands to breast cancer

Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model

Impaired myocardial blood flow reserve in subjects with metabolic syndrome analyzed using positron emission tomography and N-13 labeled ammonia

Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography